Kairos Pharma (KAPA) vs Alaunos Therapeutics (TCRT)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Kairos Pharma is the larger company by market cap ($2.7 million vs $2.3 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | KAPA | TCRT |
|---|---|---|
| Share price | $0.8103 | $0.7858 |
| Market cap | $2.74M | $2.30M |
| 1-day change | -15.55% | +0.61% |
| EPS (TTM) | $-1.96 | $-1.76 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $9.24 | $4.50 |
| 52-week low | $0.7827 | $0.72 |
| Distance from 52-week high | -91.23% | -82.54% |
| Analyst consensus | none | — |
| Avg. price target upside | +5947.14% | — |
| Average volume | 602.89K | 797.20K |
| Shares outstanding | 3.39M | 2.93M |
| Employees | 1 | 1 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Kairos Pharma
KAPA stock →Kairos Pharma, Ltd., a clinical-stage biopharmaceutical company, develops immunotherapy and cell therapies for the treatment of cancer. The company offers therapeutics, including antibodies and small molecules for the treatment of prostate cancer, lung cancer, breast cancer, and glioblastoma.
Health Care · Biotechnology: Pharmaceutical Preparations · 1 employees
About Alaunos Therapeutics
TCRT stock →Alaunos Therapeutics, Inc., a pre-clinical stage biopharmaceutical company that develops orally administered small-molecule therapeutics for the treatment of obesity and related metabolic disorders. It develops non-hormonal, non-incretin approach, and unlike hormone-based treatments, such as GLP-1 drugs.
Health Care · Biotechnology: Pharmaceutical Preparations · 1 employees
KAPA vs TCRT FAQ
Which is bigger, Kairos Pharma or Alaunos Therapeutics?
Kairos Pharma (KAPA) is larger, with a market capitalization of $2.74M compared with $2.30M for Alaunos Therapeutics (TCRT).
Are Kairos Pharma and Alaunos Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.